Research on the development of composition and technology of an emulgel with a probiotic component for the treatment of infectious and inflammatory diseases
DOI:
https://doi.org/10.24959/nphj.23.121Keywords:
pharmacological research; soft drug; emulgel; probiotics; dermatological diseasesAbstract
The aim was conducted research to develop the composition and technology of a new soft preparation under the conventional name "Probioskin" for topical use with a probiotic component in the form of an emulgel.
Materials and methods of work. The homogeneity was determined by visual inspection of the experimental samples, using a biological microscope XSP-128 ULAB. The rheological (structural and mechanical) properties of the samples were studied using a Rheolab QC rheoviscosimeter (Anton Paar, Austria) with a C-CC27/SS coaxial cylinder system. The Rheolab QC rheometer is equipped with RheoPlus software. Microbiological studies and biotesting on a biological model of infusoria were performed under aseptic conditions of a laminar flow box (biological safety cabinet AC2-4E1 "Esco", Indonesia) of the Department of Biotechnology of the National University of Pharmacy. The identification of lactobacilli and the number of live cells as critical indicators of a preparation containing live microorganisms were performed at each stage of the study. Bacterioscopic control was carried out by examining smears prepared from samples of the dissolved drug and stained by Gram stain. Bacteriological control was performed by inoculation on thick MRS-4 medium and liquid MRS-1 medium. The number of live lactobacilli (when lactobacilli were co-cultured with the drug components at the stages of development and in the finished product) was determined by surface sowing on Petri dishes with thick MRS-4 medium; after 48 h of incubation at (37±1)°C, colonies grown on the surface of the medium were counted and the number of live lactobacilli expressed in CFU was calculated in 1 ml of the drug.
Results and discussion. Based on the conducted research, the composition of a soft preparation for topical use containing dexpanthenol, lactic acid, lyophilized lactobacillus biomass, propylene glycol, peach oil, polysorbate-80, aristoflex AVC, tocopherol, and purified water was developed. The production process of the developed Probioskin product is carried out according to a standardized scheme and consists 8 stages: preparation of raw materials, preparation of oil concentrate of the probiotic component, preparation of aqueous concentrate of active substances, preparation of gel base, preparation of emulsion, dosing into tubes, packaging of tubes into packs, packaging of packs into group containers.
Conclusions. On the basis of a complex research, the composition and rational technology of a soft preparation for topical use under the conventional name "Probioskin" in the form of an emulsion was developed.
Key words: pharmacological research, soft drug, emulgel, probiotics, dermatological diseases
References
Dréno, B., Araviiskaia, E., Berardesca, E., Gontijo, G., Sanchez Viera, M., Xiang, L. F. et al. (2016). Microbiome in healthy skin, update for dermatologists. // J Eur Acad Dermatol Venere-ol, 30, 2, 2038–2047. doi: 10.1111/jdv.13965.
Shaheen, B., Gonzalez, M. (2011). A microbial aetiology of acne: what is the evidence? British Journal of Dermatology, 165, 474–485.
França, K. (2020). Topical Probiotics in Dermatological Therapy and Skincare: A Con-cise Review Dermatology and Therapy, 11, 1, 71-77. doi:1007/s13555-020-00476-7.
Mukherjee, S. (2016). Sebum and hydration levels in specific regions of human face significantly predict the nature and diversity of facial skin microbiome. Sci. Rep., 6. doi: 10.1016/j.cell.2016.04.008.
Requena, T., Velasco, M. (2021). The human microbiome in sickness and in health. Revista Clínica Española (English Edition), 221, 4, 233-240. doi: 10.1016/j.rceng.2019.07.018.
Naoki, I., Toshiro, S. (2015). Cosmetic ingredients fermented by lactic acid bacteria intestinal microbial communities associated with acute enteric infections and disease recovery. Mi-crobiome, 3, 233–242. doi: 10.1007/978-4-431-54607-8_20.
Gallo, R. L. (2017). Human skin is the largest epithelial surface for interaction with microbes. Investigation Dermatology, 137, 6. 1213–1214.
Cinque, B., La Torre, C., Marchesani, G., Zocalli, G., Palumbo, P., Di Marzio, L. et al. (2011). Use of probiotics for dermal application. Probiotics: Biology, Genetics and Health Aspects, 221-241.
Soloviova, A., Kaliuzhnaia, O., Strelnikov, L. (2020). Primary selection of the prebi-otic components in the complex dermatological therapeutic and preventive medicine with probiotic. ScienceRise: Pharmaceutical Science, 2, 24, 33-39.
Soloviova, A., Kaliuzhnaia, O., Strilets, O., Lytkin, D., Goryacha, O. (2021). The main stages of pharmaceutical development of emulgel “Probioskin”. ScienceRise: Pharmaceutical Science 6, 34, 75-84. doi: 10.15587/2519-4852.2021.249710.
Soloviova, A., Kukhtenko, H., Kaliuzhnaia, O. (2021). Substantiation of the composi-tion of a semi-solid dosage form with a probiotic component for use in dermatology. Eureka: Health Sciences, 6, 54-63. doi: 10.21303/2504-5679.2021.002181.
McLoughlin, I. J., Wright, E. M., Tagg, J. R., Jain, R., Hale J. D. F. (2022). Skin Mi-crobiome The Next Frontier for Probiotic Intervention. Probiotics Antimicrobial Proteins, 14, 4. 630–647.
Huuskonen, L., Anglenius, H., Tiihonen, K., Ouwehand, A. (2021). Probiotics and Their Various Forms Supporting Skin Health. Probiotic Research in Therapeutics, 57, 109. doi:10.1007/978–981–16–5628–6.
Jo, J. H., Kennedy, E. A., Kong, H. H. (2016). Topographical and physiological differ-ences of the skin mycobiome in health and disease. Virulence, 8, 324–333. doi: 10.1080/21505594.2016.1249093.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
